NASDAQ: TRIB
Trinity Biotech PLC Stock Ownership - Who owns Trinity Biotech?

Insider buying vs selling

Have Trinity Biotech PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TRIB insiders and whales buy or sell their stock.

TRIB Shareholders

What type of owners hold Trinity Biotech PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hunter Associates Investment Management LLC0.14%536,210$193.57kInstitution
Ronan Ocaoimh0.13%486,208$175.52kInsider
Yorkville Advisors Global LP0.06%225,000$81.23kInstitution
Williams Novak LLC0.03%107,643$38.86kInstitution
Virtu Financial LLC0.01%26,676$9.63kInstitution
Moss Adams Wealth Advisors LLC0.01%25,666$9.27kInstitution
Inspirion Wealth Advisors LLC0.01%25,000$9.03kInstitution
Cambridge Investment Research Advisors Inc0.01%22,280$8.04kInstitution
Raymond James Financial Inc0.01%20,319$7.34kInstitution
Becker Capital Management Inc0.00%18,000$6.50kInstitution

1 of 3

TRIB vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRIB0.29%0.13%
NDRA6.57%93.43%Net Buying
ADVB0.00%0.00%
MBAI0.42%0.00%
XWEL1.72%98.28%

Trinity Biotech Stock Ownership FAQ

Who owns Trinity Biotech?

Trinity Biotech (NASDAQ: TRIB) is owned by 0.29% institutional shareholders, 0.13% Trinity Biotech insiders, and 99.58% retail investors. Ronan Ocaoimh is the largest individual Trinity Biotech shareholder, owning 486,208.00 shares representing 0.13% of the company. Ronan Ocaoimh's Trinity Biotech shares are currently valued at $175.52k.

If you're new to stock investing, here's how to buy Trinity Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.